Shareholder Dilution From Stock Options
First written in FY2022-Q1. 7 of 10 entries say "Materialised", first in FY2022. Latest entry: FY2026.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026MitigatedAnnual report
「As of the date of filing this document, the number of potential shares was 73,000, equivalent to 2.2% of the total number of issued shares.」
The number and proportion of potential shares declined from 91,600 and 2.7%, respectively, in the previous disclosure to 73,000 and 2.2%, reducing the scale of the potential dilution. - FY2024MitigatedAnnual report
「As of the date of filing this document, the number of potential shares was 91,600, equivalent to 2.7% of the total number of issued shares.」
The number and proportion of potential shares declined from 141,900 and 4.3%, respectively, to 91,600 and 2.7%, while the potential for dilution through the exercise of stock options remains. - FY2024-Q3MaterialisedAnnual report
「Increase/decrease in total number of issued shares (shares) 10,000 (Note) This increase resulted from the exercise of share acquisition rights.」
From January to March 2024, 10,000 shares were issued through the exercise of share acquisition rights, further crystallising the potential dilution from potential shares. - FY2024-Q1MaterialisedAnnual report
「Increase/decrease in total number of issued shares (shares) 200 (Note) This increase resulted from the exercise of share acquisition rights.」
From July to September 2023, 200 shares were issued through the exercise of share acquisition rights, further crystallising the potential dilution from potential shares. - FY2023MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares was 141,900, equivalent to 4.3% of the total number of issued shares. The increase of 25,400 issued common shares resulted from the issuance of new shares upon the exercise of share acquisition rights.」
The number of potential shares was 141,900, or 4.3%, and 25,400 new shares were issued during the fiscal year through the exercise of share acquisition rights. The potential for dilution continues to crystallise. - FY2023-Q3MaterialisedAnnual report
「Increase/decrease in total number of issued shares (shares) 600 3,338,221 566 160,196 566 34,868 (Note) This increase resulted from the exercise of share acquisition rights.」
From January to March 2023, 600 shares were issued through the exercise of share acquisition rights, further crystallising the potential dilution. - FY2023-Q2MaterialisedAnnual report
「Increase/decrease in total number of issued shares (shares) 24,800 (Note) This increase resulted from the exercise of share acquisition rights.」
From October to December 2022, 24,800 shares were issued through the exercise of share acquisition rights, further crystallising the potential dilution from potential shares. - FY2023-Q1MaterialisedAnnual report
「At a meeting of the Company's Board of Directors held on 16 September 2022, the Company resolved to issue share acquisition rights (the Fifth Paid Stock Options) to its directors and issued them on 3 October 2022. Type and number of shares underlying the share acquisition rights: 30,000 common shares.」
Share acquisition rights covering 30,000 common shares were issued to directors, adding potential dilution from potential shares. - FY2022MaterialisedAnnual report
「As of the date of filing this document, the number of potential shares was 113,400, equivalent to 3.4% of the total number of issued shares. If these stock options are exercised, the value per share of the Company's stock could be diluted.」
The number of potential shares was 113,400, or 3.4%, while 13,000 shares were issued during the fiscal year through the exercise of share acquisition rights, partly crystallising the dilution risk. - FY2022-Q1First statedAnnual report
「As of the date of filing this document, the number of potential shares was 131,600, equivalent to 4.0% of the total number of issued shares.」
The disclosure shows the number of potential shares and their proportion of total issued shares, and describes the potential for dilution upon exercise or sale.